The role of TP53 pathogenic variants in early-onset HER2-positive breast cancer-Reference-Cited by-同舟云学术

The role of TP53 pathogenic variants in early-onset HER2-positive breast cancer

Published:2020-10-14 Issue:3 Volume:20 Page:173-180
ISSN:1389-9600
Container-title:Familial Cancer
language:en
Short-container-title:Familial Cancer

Author:

Escudeiro Carla,Pinto Carla,Vieira Joana,Peixoto Ana,Pinto Pedro,Pinheiro Manuela,Santos Catarina,Guerra Joana,Lisboa Susana,Santos Rui,Silva João,Leal Conceição,Coimbra Nuno,Lopes Paula,Ferreira Marco,Sousa Ana B.,Teixeira Manuel R.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics (clinical),Oncology,Genetics

Link

https://link.springer.com/content/pdf/10.1007/s10689-020-00212-2.pdf

Reference36 articles.

1. Bakry D, Malkin D (2013) TP53 germline mutations: genetics of Li–Fraumeni syndrome. In: Hainaut P, Olivier M, Wiman KG (eds) p53 in the clinics. Springer, New York, pp 167–188

2. van der Groep P, van der Wall E, van Diest PJ (2011) Pathology of hereditary breast cancer. Cell Oncol (Dordr) 34(2):71–88. https://doi.org/10.1007/s13402-011-0010-3

3. Li FP, Fraumeni JJF (1969) Soft-TISSUE SARCOMAS, BREAST CANCER, AND OTHER NEOPLASMSA FAMILIAL SYNdrome? Ann Intern Med 71(4):747–752. https://doi.org/10.7326/0003-4819-71-4-747

4. Gonzalez KD, Noltner KA, Buzin CH, Gu D, Wen-Fong CY, Nguyen VQ, Han JH, Lowstuter K, Longmate J, Sommer SS, Weitzel JN (2009) Beyond Li Fraumeni syndrome: clinical characteristics of families with p53 germline mutations. J Clin Oncol 27(8):1250–1256

5. Hedenfalk I, Duggan D, Chen Y, Radmacher M, Bittner M, Simon R, Meltzer P, Gusterson B, Esteller M, Kallioniemi OP, Wilfond B, Borg A, Trent J, Raffeld M, Yakhini Z, Ben-Dor A, Dougherty E, Kononen J, Bubendorf L, Fehrle W, Pittaluga S, Gruvberger S, Loman N, Johannsson O, Olsson H, Sauter G (2001) Gene-expression profiles in hereditary breast cancer. N Engl J Med 344(8):539–548. https://doi.org/10.1056/NEJM200102223440801

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HER2 status and response to neoadjuvant anti-HER2 treatment among patients with breast cancer and Li-Fraumeni syndrome;European Journal of Cancer;2024-11

2. Pedigree analysis exploring the inconsistency between diverse phenotypes and testing criteria for germline TP53 mutations in Chinese women with breast cancer;Breast Cancer Research and Treatment;2024-06-15

3. Clinical Classification and Molecular Interpretation of Hereditary Cancer Patients with Germline Pathogenic Tp53 Variations;2024

4. Breast cancer characteristics and surgery among women with Li‐Fraumeni syndrome in Germany—A retrospective cohort study;Cancer Medicine;2021-09-26